HESKA CORPORATION (NASDAQ:HSKA) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Item 5.02
|
Departure of Directors or Certain Officers; Election of
Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
(the Company), announced that Mr. Scott Humphrey has joined the
Companys Board of Directors (the Board) after the Company
approved the increase in the size of the Board to seven
directors, all in accordance with the Companys amended and
restated bylaws (the Bylaws). A copy of the press release is
attached hereto as Exhibit 99.1 and incorporated by reference
herein. Mr. Humphrey will serve as a Class III director with his
initial term expiring in 2018 in accordance with the Bylaws, and
he has been appointed to serve as a member of the Boards
Compensation and Audit Committees. He is expected to serve in
such capacities until the Companys next annual meeting of
stockholders or until his earlier resignation or removal.
and any other person in connection with his appointment to the
Board, and there are and have been no transactions since January
1, 2016, or any currently proposed transaction, in which the
Company was or is to be a participant in excess of $120,000 and
in which Mr. Humphrey had or will have a direct or indirect
material interest. Mr. Humphreys compensation for service as a
non-employee director will be consistent with that of the
Companys other non-employee directors.
|
Exhibit No.
|
Exhibit Description
|
|
|
99.1
|
Press release of the Company dated June 13, 2017
|
|
About HESKA CORPORATION (NASDAQ:HSKA)
Heska Corporation develops, manufactures, markets, sells and supports veterinary products. The Company focuses on the canine and feline companion animal health markets. Its segments include Core Companion Animal Health segment, which includes, primarily for canine and feline use, blood testing instruments and supplies, digital imaging products, software and services, and single use products and services, such as heartworm diagnostic tests, heartworm preventive products, allergy immunotherapy products and allergy testing, and Other Vaccines, Pharmaceuticals and Products segment, which includes private label vaccine and pharmaceutical production, primarily for cattle but also for other animals, including small mammals. It offers blood testing instruments and supplies, digital imaging products, software and services, and single use products and services, such as in-clinic heartworm diagnostic tests, heartworm preventive products, allergy immunotherapy products and allergy testing.
